Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Metacrine, Inc. | EVP, Gen. Counsel & Secretary | Common Stock | 3.85K | $1.81K | $0.47 | May 5, 2021 | Direct |
TFF Pharmaceuticals, Inc. | Director | Restricted stock units | 3.56K | $1.39K | $0.39 | Apr 18, 2024 | Direct |
TFF Pharmaceuticals, Inc. | Director | Common Stock | 1.58K | $620 | $0.39 | Jul 3, 2024 | Direct |
TFF Pharmaceuticals, Inc. | Director | Stock Options (Right to Buy) | 1.58K | Jul 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TFFP | TFF Pharmaceuticals, Inc. | Jul 3, 2024 | 2 | $0 | 4 | Jul 8, 2024 | Director |
TFFP | TFF Pharmaceuticals, Inc. | Apr 18, 2024 | 1 | $0 | 4 | Apr 22, 2024 | Director |
TFFP | TFF Pharmaceuticals, Inc. | Dec 1, 2023 | 1 | $0 | 4 | Dec 4, 2023 | Director |
TFFP | TFF Pharmaceuticals, Inc. | Dec 1, 2023 | 0 | $0 | 3 | Dec 4, 2023 | Director |
MTCR | Metacrine, Inc. | May 5, 2021 | 1 | $0 | 4 | May 7, 2021 | EVP, Gen. Counsel & Secretary |